Gene · 6095
Papers4,444
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 4,444
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Diagnosis potential of subarachnoid hemorrhage using miRNA signatures isolated from plasma-derived extracellular vesicles. | Front Pharmacol | 2023 | 36860299 | PubTator, text mining | PubMed |
| The role of microRNAs in the molecular link between circadian rhythm and autism spectrum disorder. | Anim Cells Syst (Seoul) | 2023 | 36860270 | PubTator, text mining | PubMed |
| Circadian Rhythms and Astrocytes: The Good, the Bad, and the Ugly. | Annu Rev Neurosci | 2023 | 36854316 | PubTator, text mining | PubMed |
| High-throughput screening for myelination promoting compounds using human stem cell-derived oligodendrocyte progenitor cells. | iScience | 2023 | 36852281 | PubTator, text mining | PubMed |
| The co-inhibitory receptor TIGIT regulates NK cell function and is upregulated in human intrahepatic CD56bright NK cells. | Front Immunol | 2023 | 36845105 | PubTator, text mining | PubMed |
| Effects of Hydroxytyrosol in Endothelial Functioning: A Comprehensive Review. | Molecules | 2023 | 36838850 | PubTator, text mining | PubMed |
| Differential Effect of Fructose in the Presence or Absence of Fatty Acids on Circadian Metabolism in Hepatocytes. | Metabolites | 2023 | 36837757 | PubTator, text mining | PubMed |
| Emerging Role of Plant-Based Dietary Components in Post-Translational Modifications Associated with Colorectal Cancer. | Life (Basel) | 2023 | 36836621 | PubTator, text mining | PubMed |
| Novel Therapeutic Potential of Retinoid-Related Orphan Receptor α in Cardiovascular Diseases. | Int J Mol Sci | 2023 | 36834872 | PubTator, text mining | PubMed |
| The Vitamin D Receptor as a Potential Target for the Treatment of Age-Related Neurodegenerative Diseases Such as Alzheimer's and Parkinson's Diseases: A Narrative Review. | Cells | 2023 | 36831327 | PubTator, text mining | PubMed |
| Neuroprotective Effect of Melatonin on Sleep Disorders Associated with Parkinson's Disease. | Antioxidants (Basel) | 2023 | 36829955 | PubTator, text mining | PubMed |
| Exploiting Multi-Omics Profiling and Systems Biology to Investigate Functions of TOMM34. | Biology (Basel) | 2023 | 36829477 | PubTator, text mining | PubMed |
| Genome-wide association study of the age of onset of type 1 diabetes reveals HTATIP2 as a novel T cell regulator. | Front Immunol | 2023 | 36817429 | PubTator, text mining | PubMed |
| Breast cancer tumor microenvironment affects Treg/IL-17-producing Treg/Th17 cell axis: Molecular and therapeutic perspectives. | Mol Ther Oncolytics | 2023 | 36816749 | PubTator, text mining | PubMed |
| RNA sequencing indicates widespread conservation of circadian clocks in marine zooplankton. | NAR Genom Bioinform | 2023 | 36814456 | PubTator, text mining | PubMed |
| Metagenomic and single-cell RNA-Seq survey of the Helicobacter pylori-infected stomach in asymptomatic individuals. | JCI Insight | 2023 | 36810249 | PubTator, text mining | PubMed |
| Identification and characterization of the long non-coding RNA NFIA-AS2 as a novel locus for body mass index in American Indians. | Int J Obes (Lond) | 2023 | 36806387 | PubTator, text mining | PubMed |
| Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions. | Signal Transduct Target Ther | 2023 | 36797231 | PubTator, text mining | PubMed |
| Omics approaches to understanding the efficacy and safety of disease-modifying treatments in multiple sclerosis. | Front Genet | 2023 | 36793897 | PubTator, text mining | PubMed |
| Prenatal exposure of diabetes and progestin-mediated autistic biomarker in peripheral blood mononuclear cells. | Eur J Neurosci | 2023 | 36788114 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6095/papers?page=32